France Redefines Diagnostic Reimbursement with the First AI-Enabled and Genomic Tests Under RIHN 2.0 France has entered a new era of evidence-based reimbursement for diagnostic innovation.On 5 June 2025, the …
This website uses cookies to improve your experience. We'll assume you're ok with this, but if you require more information click the 'Read More' linkAcceptRead More